CPT 01992: Anesthesia for Nerve Block or Injection, Prone or Supine
Commercial payers pay $70 on average nationally for this procedure.
CPT code 01992 describes anesthesia services provided when an anesthesia clinician administers or manages anesthesia for a diagnostic or therapeutic nerve block or injection performed by another provider, with the patient positioned prone or lying flat; service type: anesthesia for nerve block/injection; typical site of service: procedure suite, ambulatory surgical center, or hospital-based operating or procedure room where nerve blocks/injections are performed.
For related coverage guidance, see recent payer policy updates: Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric or Substance Use Disorders, Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric or Substance Use Disorders, Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric or Substance Use Disorders.
Customize your policy alerts
Sign up for cpt 01992 policy alerts
Get alerted when payer policies referencing 01992 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
For CPT 01992 the average commercial benchmark is represented by BUCA at $70.3, while individual commercial payers show distinct central tendencies: Aetna’s median is $61, Blue Cross Blue Shield’s median is $52.3, Cigna’s median is $87, and UnitedHealth Group’s median is $63.8. Cigna posts the highest mean at $97.2 and the highest single observed max at $159.20, while UnitedHealth Group’s max is constrained to $122.70; these central measures indicate Cigna pays notably above the BUCA average and BCBS sits below it.
Examining dispersion using the interquartile spread (P75 minus P25) highlights variability: Aetna’s IQR is $40.7, Blue Cross Blue Shield’s IQR is $38.4, BUCA’s IQR is $44.8, Cigna’s IQR is $55.7, and UnitedHealth Group’s IQR is $28.9. UnitedHealth Group displays the tightest payer band at $28.9, while Cigna is the widest at $55.7, suggesting Cigna’s commercial reimbursements are the most variable around its central tendency and UnitedHealth Group’s are the most consistent.